Abiopharma

News list

(88% Positive) APPLIED MOLECULAR TRANSPORT INC. (AMTI) Provides Update on steps for AMT-126

Full text

News bot Oct. 1, 2025, 9:06 p.m.
📋 APPLIED MOLECULAR TRANSPORT INC. (AMTI) - Clinical Trial Update

Filing Date: 2022-05-18

Accepted: 2022-05-18 08:18:33

Event Type: Clinical Trial Update
Event Details:
Applied Molecular Transport Inc (merged with Cyclo Therapeutics (CYTH)) (AMTI) Announces Clinical Trial Update Applied Molecular Transport Inc (merged with Cyclo Therapeutics (CYTH)) (AMTI) provided an update on its clinical development programs. Clinical Development Highlights:
Drug Program: steps
Diseases/Conditions: AMT-126
Clinical Stage: Phase 3, Phase 2 trial
Collaboration: • Pausing
anticipated in 2022
💼 Business Developments:
- Partnership
- Acquisition: Not available
- Licensing: Not available
- Regulatory Approval
- Executive Changes: Not available
Structured Data:
- Company Name: Applied Molecular Transport Inc (merged with Cyclo Therapeutics (CYTH))
- CIK: 0001801777
- Ticker Symbol: AMTI
- Period End Date: 2022-05-13
- Document Type: 8-K